In recognising Novotech for the prestigious award, Frost & Sullivan’s Asia Pacific Healthcare Practice Industry Manager Sanjeev Kumarsaid “Novotech was recognised as a top CRO in Australia and Asia Pacific for excellence in service provision to biopharma clients. The company has exhibited strong growth in a complex environment and now has a physical presence in 11 Asia Pacific countries. It continues to invest in cutting-edge technology, in order to provide a high quality integrated service to its clients… Novotech’s unique focus as an Asia Pacific headquartered midsize CRO ideally complements the growing needs of the biotech community.”
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…
Hong Kong - Novotech, the leading Asia P
Read more